Jeffrey S. Farrow
V.P., Finance and CAO, RENOVIS INC.
Companies
- ACHIEVE LIFE SCIENCES, INC.Board member Jun 2, 2026 to now1
- Tarsus Pharmaceuticals, Inc.Officer Apr 26, 2023 to now2
- Global Blood Therapeutics, Inc.Chief financial officer Apr 4, 2016 to Oct 6, 20223
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tarsus Pharmaceuticals, Inc. TARS56,801 shares4$4.0M at $69.64Jun 16, 2026
- ACHIEVE LIFE SCIENCES, INC. ACHV0 shares5Jun 2, 2026
- Global Blood Therapeutics, Inc.0 shares6Oct 5, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 16, 2026Sold 14,396 shares at $60.95 of Tarsus Pharmaceuticals, Inc.4
- Jun 15, 2026Exercised options 27,881 shares of Tarsus Pharmaceuticals, Inc.4
- Mar 19, 2026Sold 2,186 shares at $67.00 of Tarsus Pharmaceuticals, Inc.7
- Mar 18, 2026Sold 2,133 shares at $68.71 of Tarsus Pharmaceuticals, Inc.7
- Mar 17, 2026Sold 2,111 shares at $69.42 of Tarsus Pharmaceuticals, Inc.7
- Mar 15, 2026Exercised options 13,042 shares of Tarsus Pharmaceuticals, Inc.8
- Jun 17, 2025Sold 13,608 shares at $40.42 of Tarsus Pharmaceuticals, Inc.9
- Jun 16, 2025Exercised options 27,881 shares of Tarsus Pharmaceuticals, Inc.9
- Mar 20, 2025Sold 1,186 shares at $50.11 of Tarsus Pharmaceuticals, Inc.10
- Mar 19, 2025Sold 1,254 shares at $47.40 of Tarsus Pharmaceuticals, Inc.10
- Mar 18, 2025Sold 1,284 shares at $46.29 of Tarsus Pharmaceuticals, Inc.10
- Mar 15, 2025Exercised options 8,019 shares of Tarsus Pharmaceuticals, Inc.11
- Jun 18, 2024Sold 10,445 shares at $27.47 of Tarsus Pharmaceuticals, Inc.12
- Jun 17, 2024Exercised options 27,881 shares of Tarsus Pharmaceuticals, Inc.12
- Oct 5, 2022Returned to company 26,739 shares of Global Blood Therapeutics, Inc.6
- Sep 27, 2022Exercised options 23,653 shares at $16.40 of Global Blood Therapeutics, Inc.13
- Sep 1, 2022Sold 31,441 shares at $68.00 of Global Blood Therapeutics, Inc.14
- Sep 1, 2022Shares withheld for tax 1,885 shares at $68.15 of Global Blood Therapeutics, Inc.14
- Sep 1, 2022Exercised options 2,208 shares of Global Blood Therapeutics, Inc.14
- Sep 1, 2022Exercised options 2,763 shares of Global Blood Therapeutics, Inc.14
- Aug 1, 2022Shares withheld for tax 2,126 shares at $32.40 of Global Blood Therapeutics, Inc.15
- Aug 1, 2022Exercised options 6,145 shares of Global Blood Therapeutics, Inc.15
- Mar 1, 2022Shares withheld for tax 1,315 shares at $29.87 of Global Blood Therapeutics, Inc.16
- Mar 1, 2022Exercised options 2,763 shares of Global Blood Therapeutics, Inc.16
- Feb 1, 2022Shares withheld for tax 4,506 shares at $29.33 of Global Blood Therapeutics, Inc.17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Mar 19, 2026
- 8SEC EDGARForm 4 filed Mar 17, 2026
- 9SEC EDGARForm 4 filed Jun 18, 2025
- 10SEC EDGARForm 4 filed Mar 20, 2025
- 11SEC EDGARForm 4 filed Mar 18, 2025
- 12SEC EDGARForm 4 filed Jun 20, 2024
- 13SEC EDGARForm 4 filed Sep 29, 2022
- 14SEC EDGARForm 4 filed Sep 6, 2022
- 15SEC EDGARForm 4 filed Aug 3, 2022
- 16SEC EDGARForm 4 filed Mar 3, 2022
- 17SEC EDGARForm 4 filed Feb 3, 2022